Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian Cancer

13 Apr 2020

Abstract excerpt

Ovarian cancer (OC) is the deadliest gynecologic malignancy with a substantial proportion of hereditary cases and a frequent association with breast cancer (BC). Genetic testing facilitates treatment and preventive strategies reducing OC mortality in mutation carriers. However, the prevalence of germline mutations varies among populations and many rarely mutated OC predisposition genes remain to be identified. We...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to BRCA gene mutations in cancer
Share to Ovarian cancer diagnosis and treatment
Share to PARP inhibition in cancer therapy

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 32295079
DOI: 10.3390/cancers12040956

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 1 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Multigene Panel Germline Testing of 1333 Czech Patients with Ovarian CancerPMID 32295079Read ↗

Spectrum and Prevalence of Pathogenic Variants in Ovarian Cancer Susceptibility Genes in a Group of 333 PatientsSemantic proximity Read ↗

Next-Generation Sequencing Analysis of Hereditary Ovarian Cancer Gene Panels in Turkish PopulationSemantic proximity Read ↗

Detection of Germline Mutations in Patients with Epithelial Ovarian Cancer Using Multi-gene Panels: Beyond BRCA1/2Semantic proximity Read ↗

Germline mutational variants of Turkish ovarian cancer patients suspected of Hereditary Breast and Ovarian Cancer (HBOC) by next-generation sequencing.Semantic proximity Read ↗

Inherited Mutations in Women With Ovarian Carcinoma.Semantic proximity Read ↗

Pathogenic Variants in BRIP1, RAD51C, and RAD51D Identified with Multi-Gene Panel Testing for Hereditary CancersSemantic proximity Read ↗

Germline and somatic mutations of multi-gene panel in Chinese patients with epithelial ovarian cancer: a prospective cohort studySemantic proximity Read ↗

Impact of non-BRCA genes in the indication of risk-reducing surgery in hereditary breast and ovarian cancer syndrome (HBOC).Semantic proximity Read ↗

Time to incorporate germline multigene panel testing into breast and ovarian cancer patient care.Semantic proximity Read ↗

Early-Onset Ovarian Cancer <30 Years: What Do We Know about Its Genetic Predisposition?Semantic proximity Read ↗

Extended panel testing in ovarian cancer reveals BRIP1 as the third most important predisposition gene.Semantic proximity Read ↗

Frequency of mutations in a large series of clinically ascertained ovarian cancer cases tested on multi-gene panels compared to reference controls.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.